Enter your keywords

Optimising the use of morphine 10mg/5mL oral solution in primary care (Update)

Opioids are effective for acute pain and pain at the end of life, but there is little evidence of their effectiveness for long term pain. This document supports primary care teams to review patients receiving regular large quantities of morphine 10mg/5mL oral solution and includes advice on how these patients could be managed. This publication […]

Formulary assessment – melatonin (Adaflex) for ADHD

Formulary assessment tools are templates to support local decision making. They list NICE guidance, MHRA safety advice, and other relevant high quality advice and guidelines relevant to making decisions for local formularies. The templates are pre-populated with useful information to reduce duplication of effort, with space for the addition of local information as appropriate. The […]

Formulary assessment – Dacepton (apomorphine)

Formulary assessment tools are templates to support local decision making. They list NICE guidance, MHRA safety advice, and other relevant high quality advice and guidelines relevant to making decisions for local formularies. The templates are pre-populated with useful information to reduce duplication of effort, with space for the addition of local information as appropriate. The […]

Antidepressant drugs

This report looks at prescribing trends in primary care for Antidepressant drugs at CCG and STP level with particular focus on first choice antidepressant prescribing and exploration of associations between prescribing and improving access to psychological therapies. If you have any queries about the content of the report please contact us at nuth.nyrdtc.rxsupp@nhs.net Frequency Annually […]

Pain Management

This report looks at prescribing trends in primary care in relation to Pain Management at CCG and STP level with particular focus on Opioid and Non-opioid analgesics, Neuropathic pain, Antimigraine drugs and Osteoarthritis. If you have any queries about the content of the report please contact us at nuth.nyrdtc.rxsupp@nhs.net Frequency Bi-annually Data Period April 2019 […]

Drugs for Dementia

This report looks at prescribing trends in primary care for Drugs for Dementia at CCG and STP level with particular focus on low strength antipsychotics. Prescribing data is weighted with QoF registers. If you have any queries about the content of the report please contact us at nuth.nyrdtc.rxsupp@nhs.net Frequency Quarterly Data Period April 2019 to […]

Solriamfetol for obstructive sleep apnoea

Solriamfetol is indicated to improve wakefulness and reduce excessive daytime sleepiness (EDS) in adult patients with obstructive sleep apnoea (OSA) whose EDS has not been satisfactorily treated by primary OSA therapy, such as continuous positive airway pressure (CPAP). This publication reviews its efficacy and safety, and the limitations of the evidence. Solriamfetol is also licensed […]

Solriamfetol for narcolepsy

Solriamfetol is indicated to improve wakefulness and reduce excessive daytime sleepiness (EDS) in adult patients with narcolepsy with or without cataplexy. This publication reviews its efficacy and safety, and the limitations of the evidence. Solriamfetol is also licensed to improve wakefulness and reduce EDS in adults with obstructive sleep apnoea (see separate RDTC evaluation).

Impact of Priadel Price Change on CCG Prescribing Budgets

This bulletin aims to raise awareness of the NHS price increase for Priadel® (lithium carbonate) tablets as of November 2020 and the resulting cost impact to primary care. While discussions between the DHSC and the manufacturer of Priadel have prevented its discontinuation from the UK market at this stage, the renegotiated price in November 2020 […]